Mark L Perry - Net Worth and Insider Trading
Mark L Perry Net Worth
The estimated net worth of Mark L Perry is at least $235 Million dollars as of 2024-04-27. Mark L Perry is the Director of NVIDIA Corp and owns about 138,612 shares of NVIDIA Corp (NVDA) stock worth over $122 Million. Mark L Perry is the EVP Operations of Gilead Sciences Inc and owns about 1,613,120 shares of Gilead Sciences Inc (GILD) stock worth over $106 Million. Mark L Perry is also the Director of MyoKardia Inc and owns about 25,408 shares of MyoKardia Inc (MYOK) stock worth over $6 Million. Besides these, Mark L Perry also holds Global Blood Therapeutics Inc (GBT) . Details can be seen in Mark L Perry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark L Perry has not made any transactions after 2024-02-23 and currently still holds the listed stock(s).
Transaction Summary of Mark L Perry
Mark L Perry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark L Perry owns 5 companies in total, including MyoKardia Inc (MYOK) , Global Blood Therapeutics Inc (GBT) , and NVIDIA Corp (NVDA) among others .
Click here to see the complete history of Mark L Perry’s form 4 insider trades.
Insider Ownership Summary of Mark L Perry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MYOK | MyoKardia Inc | 2020-06-18 | director |
| GBT | Global Blood Therapeutics Inc | 2020-05-12 | director |
| NVDA | NVIDIA Corp | 2024-02-23 | director |
| ABIO | ARCA biopharma Inc | 2003-10-13 | director |
| GILD | Gilead Sciences Inc | 2004-02-03 | EVP Operations |
Mark L Perry Latest Holdings Summary
Mark L Perry currently owns a total of 4 stocks. Among these stocks, Mark L Perry owns 138,612 shares of NVIDIA Corp (NVDA) as of February 23, 2024, with a value of $122 Million and a weighting of 51.82%. Mark L Perry owns 1,613,120 shares of Gilead Sciences Inc (GILD) as of February 3, 2004, with a value of $106 Million and a weighting of 44.97%. Mark L Perry also owns 25,408 shares of MyoKardia Inc (MYOK) as of November 3, 2015, with a value of $6 Million and a weighting of 2.44%. The other 1 stocks Global Blood Therapeutics Inc (GBT) have a combined weighting of 0.77% among all his current holdings.
Latest Holdings of Mark L Perry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVDA | NVIDIA Corp | 2024-02-23 | 138,612 | 877.35 | 121,611,238 |
| GILD | Gilead Sciences Inc | 2004-02-03 | 1,613,120 | 65.42 | 105,530,310 |
| MYOK | MyoKardia Inc | 2015-11-03 | 25,408 | 224.91 | 5,714,513 |
| GBT | Global Blood Therapeutics Inc | 2020-05-12 | 26,428 | 68.49 | 1,810,054 |
Holding Weightings of Mark L Perry
Mark L Perry Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark L Perry has made a total of 6 transactions in NVIDIA Corp (NVDA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in NVIDIA Corp is the sale of 15,000 shares on February 23, 2024, which brought Mark L Perry around $12 Million.
According to the SEC Form 4 filings, Mark L Perry has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 397,728 shares on February 3, 2004, which brought Mark L Perry around $3 Million.
According to the SEC Form 4 filings, Mark L Perry has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the acquisition of 5,000 shares on November 3, 2015, which cost Mark L Perry around $50,000.
More details on Mark L Perry's insider transactions can be found in the Insider Trading History of Mark L Perry table.Insider Trading History of Mark L Perry
- 1
Mark L Perry Trading Performance
GuruFocus tracks the stock performance after each of Mark L Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark L Perry is -14.67%. GuruFocus also compares Mark L Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark L Perry within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark L Perry's insider trading performs compared to the benchmark.
Performance of Mark L Perry
Average Return
-17.47%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.59 | -14.67 | -22.98 | -17.47 | 37.78 | 37.85 |
| Relative Return to S&P 500(%) | 14.69 | -8.76 | -17.71 | -18.86 | 28.66 | 28.08 |
Mark L Perry Ownership Network
Ownership Network List of Mark L Perry
Ownership Network Relation of Mark L Perry
Mark L Perry Owned Company Details
What does MyoKardia Inc do?
Who are the key executives at MyoKardia Inc?
Mark L Perry is the director of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .
MyoKardia Inc (MYOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
MyoKardia Inc Insider Transactions
Mark L Perry Mailing Address
Above is the net worth, insider trading, and ownership report for Mark L Perry. You might contact Mark L Perry via mailing address: 176 West Blithedale Ave, Mill Valley Ca 94941.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
